Technical Analysis for NGEN - Nervgen Pharma Corp
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Flat | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Lower Bollinger Band Touch | Weakness | 10.00% | |
| Oversold Stochastic | Weakness | 10.00% | |
| Stochastic Reached Oversold | Weakness | 11.11% | |
| Down 3 Days in a Row | Weakness | 11.11% | |
| Oversold Stochastic | Weakness | 11.11% | |
| Gapped Up | Strength | 8.91% | |
| 1,2,3 Retracement Bearish | Bearish Swing Setup | 1.85% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 1.85% | |
| Narrow Range Bar | Range Contraction | 1.85% | |
| Inside Day | Range Contraction | 1.85% |
| Alert | Time |
|---|---|
| Possible Pocket Pivot | 17 minutes ago |
| Rose Above 20 DMA | 17 minutes ago |
| Rose Above 200 DMA | 17 minutes ago |
| Up 1 ATR | about 1 hour ago |
| 20 DMA Resistance | about 1 hour ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 2024-05-13
NervGen Pharma Corp. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of nerve damage. Its product candidate is the NVG-291 that is in clinical studies for the treatment of spinal cord injuries (SCI). It has a licensing agreement with Case Western Reserve University of Cleveland, Ohio to research, develop, and commercialize a patented technology with therapeutic potential for SCI and other conditions associated with nerve damage. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Pharma Pharmaceutical Clinic Pharmaceutical Products
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Pharma Pharmaceutical Clinic Pharmaceutical Products
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.98 |
| 52 Week Low | 1.5 |
| Average Volume | 104,816 |
| 200-Day Moving Average | 2.199 |
| 50-Day Moving Average | 2.764 |
| 20-Day Moving Average | 2.175 |
| 10-Day Moving Average | 2.105 |
| Average True Range | 0.152 |
| RSI (14) | 33.33 |
| ADX | 41.55 |
| +DI | 9.603 |
| -DI | 38.153 |
| Chandelier Exit (Long, 3 ATRs) | 2.284 |
| Chandelier Exit (Short, 3 ATRs) | 2.326 |
| Upper Bollinger Bands | 2.411 |
| Lower Bollinger Band | 1.938 |
| Percent B (%b) | 0.13 |
| BandWidth | 21.789 |
| MACD Line | -0.189 |
| MACD Signal Line | -0.196 |
| MACD Histogram | 0.0078 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.270 | ||||
| Resistance 3 (R3) | 2.257 | 2.153 | 2.225 | ||
| Resistance 2 (R2) | 2.153 | 2.085 | 2.160 | 2.210 | |
| Resistance 1 (R1) | 2.077 | 2.042 | 2.115 | 2.090 | 2.195 |
| Pivot Point | 1.973 | 1.973 | 1.993 | 1.980 | 1.973 |
| Support 1 (S1) | 1.897 | 1.905 | 1.935 | 1.910 | 1.805 |
| Support 2 (S2) | 1.793 | 1.862 | 1.800 | 1.790 | |
| Support 3 (S3) | 1.717 | 1.793 | 1.775 | ||
| Support 4 (S4) | 1.730 |
